ELAN
Elanco Animal Health Incorporated
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$24.38
−0.14%5
Insider buys (3m)
0
Insider sells (3m)
$1.5M
Net value (3m)
+4.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 25, 2026 | Simmons Jeffrey N · director, officer: PRESIDENT, CEO AND DIRECTOR | A-Award | 118 | $0.00 |
| Aug 25, 2026 | Modi Rajeev A. · officer: SEE REMARKS | A-Award | 62 | $0.00 |
| Aug 25, 2026 | VanHimbergen Robert M · officer: EVP and CFO | A-Award | 8 | $0.00 |
| Aug 21, 2026 | Kurzius Lawrence Erik · director | Purchase | 40,000 | $23 |
| Aug 18, 2026 | O'Neill Shiv · officer: GC AND CORP SEC | Purchase | 3,998 | $24 |
| Aug 13, 2026 | Harrington Michael J · director | Purchase | 5,000 | $22 |
| Aug 10, 2026 | VanHimbergen Robert M · officer: EVP and CFO | A-Award | 9 | $0.00 |
| Aug 10, 2026 | VanHimbergen Robert M · officer: EVP and CFO | Purchase | 4,200 | $23 |
| Aug 10, 2026 | Modi Rajeev A. · officer: SEE REMARKS | A-Award | 67 | $0.00 |
| Aug 10, 2026 | Simmons Jeffrey N · director, officer: PRESIDENT, CEO AND DIRECTOR | A-Award | 128 | $0.00 |
| Aug 10, 2026 | Herendeen Paul · director | Purchase | 10,000 | $24 |
| Jul 28, 2026 | VanHimbergen Robert M · officer: EVP and CFO | A-Award | 8 | $0.00 |
| Jul 28, 2026 | Simmons Jeffrey N · director, officer: PRESIDENT, CEO AND DIRECTOR | A-Award | 113 | $0.00 |
| Jul 28, 2026 | Modi Rajeev A. · officer: SEE REMARKS | A-Award | 59 | $0.00 |
| Jul 14, 2026 | VanHimbergen Robert M · officer: EVP and CFO | A-Award | 8 | $0.00 |
| Jul 14, 2026 | Simmons Jeffrey N · director, officer: PRESIDENT, CEO AND DIRECTOR | A-Award | 114 | $0.00 |
| Jul 14, 2026 | Modi Rajeev A. · officer: SEE REMARKS | A-Award | 60 | $0.00 |
| Jul 9, 2026 | VanHimbergen Robert M · officer: EVP and CFO | F-InKind | 15,336 | $25 |
| Jul 2, 2026 | Anand Kapila K · director | A-Award | 584 | $0.00 |
| Jul 2, 2026 | Kinard David S · officer: SEE REMARKS | A-Award | 25,620 | $24 |
| Jun 30, 2026 | VanHimbergen Robert M · officer: EVP and CFO | A-Award | 8 | $0.00 |
| Jun 30, 2026 | Simmons Jeffrey N · director, officer: PRESIDENT, CEO AND DIRECTOR | A-Award | 115 | $0.00 |
| Jun 30, 2026 | Modi Rajeev A. · officer: SEE REMARKS | A-Award | 60 | $0.00 |
| Jun 16, 2026 | VanHimbergen Robert M · officer: EVP and CFO | A-Award | 8 | $0.00 |
| Jun 16, 2026 | Simmons Jeffrey N · director, officer: PRESIDENT, CEO AND DIRECTOR | A-Award | 117 | $0.00 |
| Jun 16, 2026 | Modi Rajeev A. · officer: SEE REMARKS | A-Award | 61 | $0.00 |
| Jun 2, 2026 | Modi Rajeev A. · officer: SEE REMARKS | A-Award | 62 | $0.00 |
| Jun 2, 2026 | VanHimbergen Robert M · officer: EVP and CFO | A-Award | 8 | $0.00 |
| Jun 2, 2026 | Simmons Jeffrey N · director, officer: PRESIDENT, CEO AND DIRECTOR | A-Award | 119 | $0.00 |
| May 26, 2026 | Kurzius Lawrence Erik · director | A-Award | 4,678 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 175Increased 356Reduced 375Sold out 72
| Filer | Action | Shares | Filed |
|---|---|---|---|
| DODGE & COX | Reduced | 68,944,100 | May 14, 2026 |
| DODGE & COX | Reduced | 67,397,025 | Aug 13, 2026 |
| FMR LLC | Increased | 56,948,819 | Aug 13, 2026 |
| FMR LLC | Reduced | 50,925,366 | May 15, 2026 |
| BlackRock, Inc. | Increased | 48,849,973 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 47,622,630 | May 13, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Reduced | 45,840,956 | May 11, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Reduced | 45,445,012 | Aug 14, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Reduced | 34,635,086 | May 15, 2026 |
| T. Rowe Price Investment Management, Inc. | Reduced | 28,750,719 | Aug 14, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 25,417,271 | Aug 11, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Reduced | 24,527,135 | May 7, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 22,672,312 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 22,637,357 | May 8, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 22,607,532 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 25, 2026